Opendata, web and dolomites
H2020 projects about "tumours"
The page lists 173 projects related to the topic "tumours".
| # | |||
|---|---|---|---|
| 1 | B-CAST | Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes | 2015 |
| 2 | CRCStemCellDynamics | Molecular Subtype Specific Stem Cell Dynamics in Developing and Established Colorectal Cancers | 2015 |
| 3 | Crosstag | Unravelling cross-presentation pathways using a chemical biology approach | 2015 |
| 4 | ONCORNET | ONCOgenic Receptor Network of Excellence and Training | 2015 |
| 5 | InSPECT | Integrated Spectrometers for Spectral Tissue Sensing | 2015 |
| 6 | VIBRA | Very fast Imaging by Broadband coherent RAman | 2015 |
| 7 | Brain Metastases | The Role of Circulating Monocytes in the Development of Brain Metastases | 2015 |
| 8 | Tolltum | Role, regulation and targeting of nucleic acid-sensing TLRs within the tumour microenvironment | 2015 |
| 9 | SmartMammaCAD | Intelligent Automated System for detecting Diagnostically Challenging Breast Cancers | 2015 |
| 10 | STROMAMECH | Targeting stromal cells to modify tumor mechanical microenvironment and optimize drug delivery | 2015 |
| 11 | DC cancer | Development and immunological control of dendritic cell cancer | 2015 |
| 12 | breast cancer dormancy | Molecular characterisation of a clinical model of estrogen receptor-positive breast cancer dormancy | 2015 |
| 13 | ChemoBOOM | Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy | 2016 |
| 14 | MACROIMAGING | Specific Fluorogenic Peptides for Imaging Metastasis-associated Macrophages | 2015 |
| 15 | CICCI | Characterization of Intestinal Cancer Cell Invasion | 2015 |
| 16 | EGFR-Activ | Epidermal growth factor receptor (EGFR) activation by cytohesins - Structural Insights | 2015 |
| 17 | APOBEC | Enzymatic DNA deamination and the immunity/cancer balance | 2015 |
| 18 | XMED | Medical Phase Contrast X-ray Imaging with Laser Plasma Accelerator | 2015 |
| 19 | NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages | 2015 |
| 20 | RAIL | Radiomics of lung cancer (RAIL): non-invasive stratification of tumour heterogeneity for personalised cancer therapy | 2015 |
| 21 | ER_disease | Defining hormonal cross-talk and the role of mutations in estrogen receptor positive breast cancer | 2015 |
| 22 | LAUREN | bLadder cAncer URine cEll aNalysis | 2015 |
| 23 | SPICE | Synthetic Lethal Phenotype Identification through Cancer Evolution Analysis | 2015 |
| 24 | ISPIC | Image-Guided Surgery (IGS) and Personalised Postoperative Immunotherapy To Improving Cancer Outcome | 2016 |
| 25 | RNAEDIT | RNA EDITING IN HEALTH AND DISEASE | 2016 |
| 26 | MMUVR | Elucidating the role of ultraviolet radiation in melanoma | 2016 |
| 27 | COMbAT | Commercialization of a novel tool for designing personalized nOvel MelAnoma Therapies | 2015 |
| 28 | ONCOCHECK | A simple blood test to monitor disease progression in patients undergoing cancer therapy | 2015 |
| 29 | MaXIMA | Three dimensional breast cancer models for X-ray Imaging research | 2016 |
| 30 | ClearPEMplus | Enhanced Silicon Photomultiplier-based detectors for high-resolution Positron Emission Mammography. | 2015 |
| 31 | GLINT | GlucoCEST Imaging of Neoplastic Tumours | 2016 |
| 32 | CARAT | Chimeric Antigen Receptors (CARs) for Advanced Therapies | 2016 |
| 33 | FORCE | Imaging the Force of Cancer | 2016 |
| 34 | CONQUEST | Companion Nanodiagnostics for Quantifying EPR and Stratifying Patients to Targeted Nanotherapies | 2016 |
| 35 | PrECISE | PERSONALIZED ENGINE FOR CANCER INTEGRATIVE STUDY AND EVALUATION | 2016 |
| 36 | NoCut | Detection of Chromatin Bridges during Cytokinesis | 2016 |
| 37 | LDC4PCaTher | BMX-targeted ligand-drug conjugates for prostate cancer therapy | 2016 |
| 38 | iGEMMdev | Development and Characterisation of New Immunogenic GEMMs of Lung Cancer | 2017 |
| 39 | PrecTherLSCC | Precision Therapies in Lung Squamous Cell Carcinoma | 2016 |
| 40 | NuSiCC | Modelling the therapeutic potential of NUAK1 suppression in colorectal cancer | 2016 |
| 41 | INTO | Inorganic therapeutic nanoparticles for osteoporosis | 2016 |
| 42 | AVITAG | Alphaviral Immunotherapy against Glioblastoma | 2016 |
| 43 | CIRCLE | Investigation of the role of CYLD in Chronic Lymphocytic Leukaemia | 2016 |
| 44 | LDMBI | Low dose Molecular Breast Imaging for improved cancer detection in dense breast tissue. | 2016 |
| 45 | TSGPs-of-CFSs | Role of Tumour Suppressor Gene Products of Common Fragile Sites in Human Diseases | 2016 |
| 46 | NanoPokers | Deciphering cell heterogeneity in tumors using arrays of nanowires to controllably poke single cells in longitudinal studies | 2016 |
| 47 | ONCOINTRABODY | Targeting common oncogenes with intracellular monobodies | 2016 |
| 48 | DECODE | Allele-specific Deconvolution of Tumour DNA Methylation and Expression Data toReveal Underlying Cell Populations | 2016 |
| 49 | CLONCELLBREAST | CLONAL AND CELLULAR HETEROGENEITY OF BREAST CANCER AND ITS DYNAMIC EVOLUTION WITH TREATMENT | 2017 |
| 50 | LeukaemiaTargeted | Selecting genetic lesions with essential function for patients' leukaemia in vivo as targets for precision medicine | 2016 |
| 51 | GlioDx | GlioDx - Blood platelet-based monitoring and treatment optimisation for glioblastoma patients | 2016 |
| 52 | INTHER | Clinical validation and commercialization of innovative immunostimulating Interstitial Laser Thermotherapy | 2016 |
| 53 | Quality2Cells | TimeLapseReader for Quality Control of Immune Cells used for Cell-Based Therapies | 2016 |
| 54 | MATRICAN | Matrix during cancer progression | 2016 |
| 55 | BITCAT | Blocking Inhibition of T-cell Co-stimulation for Anti-tumour Therapy | 2017 |
| 56 | CONQUEST | CONQUEST: Enabling advanced medical imaging | 2016 |
| 57 | N2B-patch | Nose to Brain Delivery of antibodies via the Olfactory Region for the Treatment of Multiple Sclerosis Using Novel Multi-functional Biomaterials Combined with a Medical Device | 2017 |
| 58 | McHAP | Entrapment of Hypoxic Cancer by Macrophages Loaded with HAP | 2017 |
| 59 | NONCODRIVERS | Finding noncoding cancer drivers | 2016 |
| 60 | EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies | 2017 |
| 61 | MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer | 2017 |
| 62 | SpheroPredict | A 3D advanced test for prediction of drug response in secondary liver cancer | 2017 |
| 63 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 64 | BGCI | Bacterial Ghost Cancer Immunotherapy - A new standard in tumour therapy based on the bacterial ghost platform technology | 2017 |
| 65 | BRECASTEM | Functional and Molecular Characterisation of Breast Cancer Stem Cells | 2017 |
| 66 | GlycoModels | 3D glyco-engineered models to address the role of glycosylation in gastric cancer clinical management | 2017 |
| 67 | Survive | Surviving metabolism: acid handling and signalling | 2017 |
| 68 | MicroMechCell | Precision micromechanical lever for next-generation cell culture systems | 2017 |
| 69 | SCALTIE | Single cell analysis of the lung tumour-immune ecosystem: Developing new tools for effective immunotherapy | 2017 |
| 70 | OPN-Can | Investigating the role of OPN-CD44 in mechanosensitive tumour invasion using biomimetic models | 2017 |
| 71 | GlimS | Patient-specific tumour growth model for quantification of mechanical 'markers' in malignant gliomas: Implications for treatment outcomes. | 2017 |
| 72 | IVORIaN | RAS/C-RAF interaction: A new pharmacological target in Kras-driven lung cancer. | 2017 |
| 73 | PI3K-VAs | Activation of PI3K signalling in the pathogenesis of Vascular Anomalies | 2018 |
| 74 | DSMT16 | Deciphering causes and consequences of inflammation in subtypes of sporadic intestinal cancer | 2018 |
| 75 | PHRD | The development of Personalised Host Response Diagnostic kit | 2017 |
| 76 | BEAT | The functional interaction of EGFR and beta-catenin signalling in colorectal cancer: Genetics, mechanisms, and therapeutic potential. | 2017 |
| 77 | META-DORM | Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions | 2018 |
| 78 | altEJrepair | Characterisation of DNA Double-Strand Break Repair by Alternative End-Joining: Potential Targets for Cancer Therapy | 2017 |
| 79 | DissectPcG | Dissecting the Function of Multiple Polycomb Group Complexes in Establishing Transcriptional Identity | 2017 |
| 80 | X-Imaging | MRI diagnosis using a single-shot imaging technique with unprecedented robustness to field inhomogeneities | 2017 |
| 81 | OR-HMC | Assay for cancer diagnostics by quantification of 5hmC | 2017 |
| 82 | Tumor-Treg-Targeting | Training Network for the education of the next generation scientist in targeting the supressive capacity of regulatory T-cells specifically within tumours | 2018 |
| 83 | u-PBeam | Microdosimetry study of a new radiation therapy method based on proton minibeams | 2017 |
| 84 | AiPBAND | An Integrated Platform for Developing Brain Cancer Diagnostic Techniques | 2018 |
| 85 | CuHypMECH | New Nuclear Medicine Imaging Radiotracer 64Cu(II) for diagnosing Hypoxia Conditions Based on the Cellular Copper Cycle | 2017 |
| 86 | GLIOTRAIN | Exploiting GLIOblastoma intractability to address European research TRAINing needs in translational brain tumour research, cancer systems medicine and integrative multi-omics | 2017 |
| 87 | onCOMBINE | Towards evidence-based combinations of approved and novel cancer drugs | 2017 |
| 88 | TarMyc | Targeting the Oncogenic Function of Myc in vivo | 2018 |
| 89 | HypoRuLight | Hypoxic Tumour Models for Photoactivatable Ruthenium-based Chemotherapy | 2017 |
| 90 | EDIReX | EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts | 2018 |
| 91 | CylcoRu4PACT | Cyclometallated ruthenium complexes for photo-activated chemotherapy | 2018 |
| 92 | ToMeTuM | Towards the Understanding a Metal-Tumour-Metabolism | 2018 |
| 93 | CANCER | Personalised Postoperative Immunotherapy To Improving Cancer Outcome and improving quality of life | 2018 |
| 94 | SDS-OmiProbe | Revolutionary opto-biological methodology for aggressive HER2 cancer | 2017 |
| 95 | DiSect | The Tumour Stroma as a Driver of Clonal Selection | 2018 |
| 96 | HepaCheC | HepaCheC - an in vitro diagnostic assay for the early detection of liver cancer | 2018 |
| 97 | NIRCOThera | Spatiotemporal, near-infrared light controlled carbon monoxide delivery for cancer immunotherapy | 2018 |
| 98 | CellularNanoMachines | Development of Stimuli-Responsive Nanoparticle-carrying T lymphocytes in the Fight against Cancer | 2019 |
| 99 | DYNAFLUORS | Dynamic Activatable Fluorophores | 2018 |
| 100 | PhenoSwitch | Phenotype switching: plasticity and/or differentiation of stromal cells and their progenitors within the tumour microenvironment regulate tumour fate. | 2018 |
| 101 | MicroC | Agent-Based Modelling of Gene Networks to model clonal selection in the tumour microenvironment and predict therapeutic resistance | 2018 |
| 102 | VALSL | Valorisation of splice-switching oligonucleotides for lung cancer therapy | 2018 |
| 103 | SPeNTa-Brain | Synthetic Peptidic Nanovesicles for Targeting Paediatric Brain tumours | 2019 |
| 104 | NanoFEITH | Nanoparticles for Fluorescence-Enhanced Imaging and Therapy of Breast Cancer | 2018 |
| 105 | ORTHOCAT | Bioorthogonal Photocatalytic Activation of Metal-Based Prodrugs | 2018 |
| 106 | MITIG | Addressing MITochondrial Import by Glioblastoma cells to rewire respiratory metabolism | 2019 |
| 107 | Gal3-BrainMets | A novel immunotherapy against brain metastasis: Anti-Galectin-3 | 2019 |
| 108 | HDAC6_GEMM | Development of a novel genetically engineered mouse model to study the role of HDAC6 in oncogenesis and metastasis of non-small cell lung cancer. | 2018 |
| 109 | NANOBOTS | Tumor-Targeting Nanoengineered Bioorthogonal Technologies to Fight Metastatic Cancers | 2018 |
| 110 | 4DBIOSERS | Four-Dimensional Monitoring of Tumour Growth by Surface Enhanced Raman Scattering | 2018 |
| 111 | EVO-NANO | Evolvable platform for programmable nanoparticle-based cancer therapies | 2018 |
| 112 | HOPE | Host Protective Engineering of Cancer Immunity by Targeting the Intracellular Immune Checkpoint NR2F6 | 2018 |
| 113 | DISCOVER | Death receptor signalling in tumour immune editing | 2018 |
| 114 | KERMA | A NEW VERIFICATION SYSTEM FOR COMPLEX RADIOTHERAPY TREATMENTS | 2018 |
| 115 | SenolT | Fast and effective diagnostic test for the early detection of residual tumours to prevent cancer recurrence | 2018 |
| 116 | TARGETSS | Targeting SWI/SNF complex function in cancer | 2019 |
| 117 | ARTTOUCH | Generating artificial touch: from the contribution of single tactile afferents to the encoding of complex percepts, and their implications for clinical innovation | 2019 |
| 118 | CL-IO | Commercial feasibility of non-pathogenic Clostridium-Mediated Cancer Immunotherapy: leveraging the presence of tumour hypoxia & necrosis | 2018 |
| 119 | CytoPro | A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up | 2018 |
| 120 | PRIMAGE | PRedictive In-silico Multiscale Analytics to support cancer personalized diaGnosis and prognosis, Empowered by imaging biomarkers | 2018 |
| 121 | GLADIATOR | Next-generation theranostics of brain pathologies with autonomous externally controllable nanonetworks: a trans-disciplinary approach with bio-nanodevice interfaces | 2019 |
| 122 | FRINGE | Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies | 2019 |
| 123 | CANCEREVO | Deciphering and predicting the evolution of cancer cell populations | 2019 |
| 124 | FanCY | Flow and Deformation of Cancer tumours near Yielding | 2019 |
| 125 | PROTONMBRT | Spatial fractionation of the dose in proton therapy: a novel therapeutic approach | 2019 |
| 126 | ONCOFUM | Integrating the tissue-specificity and chronology of hereditary renal cancer predisposition | 2019 |
| 127 | iPC | individualizedPaediatricCure: Cloud-based virtual-patient models for precision paediatric oncology | 2019 |
| 128 | PRO-TOOLKITS | Programmable nucleic acid toolkits for cell-free diagnostics and genetically encoded biosensing | 2019 |
| 129 | PICModForPCa | Personalised Image-based Computational Modelling Framework to Forecast Prostate Cancer | 2020 |
| 130 | SYNKIT | Synthetic Natural Killer Cells for Immunotherapy | 2020 |
| 131 | Oncogenic PI3-kinase | New biology of oncogenic PI 3-kinase | 2019 |
| 132 | GLIOHAB | Multiparametric imaging of glioblastoma tumour heterogeneity for supporting treatment decisions and accurate prognostic estimation | 2019 |
| 133 | THERMOGUIDE | Optimizing delivery and effectiveness of chemotherapy in breast cancer patients using thermotherapy under image-guidance | 2019 |
| 134 | EVOMET | The rise and fall of metastatic clones under immune attack | 2019 |
| 135 | DC Metabolism | Metabolic Regulation of Conventional Dendritic Cell Development and Function | 2020 |
| 136 | MacrophInt | Targeting integrin signaling in tumour-associated macrophages to combat cancer progression and resistance | 2019 |
| 137 | MHT-ImmunoEnhancer | Stimuli-Responsive Nanoplatform to Combine Magnetic Hyperthermia with Immunemodulators Delivery for Glioblastoma Treatment | 2019 |
| 138 | PRINT-CHEMO | To develop 3D bioPRINTed osteoinductive constructs that deliver CHEMOtherapeutics within large bone defects that are surgically created when removing bone tumours. | 2019 |
| 139 | CentrosoTME | The role of extra centrosomes on the tumour microenvironment | 2019 |
| 140 | PanILC | Deciphering type 2 innate lymphoid cell/epithelial progenitor cell crosstalk in pancreas regeneration and neoplasia | 2019 |
| 141 | PhotoStem | Photoswitching molecules for the spatiotemporal control of cancer stem cells with light | 2019 |
| 142 | INFORM | Innovative Electrochemical Multiplex Biosensor for Detection and Quantification of Clinically Relevant Circulating miRNAs | 2020 |
| 143 | CancerADAPT | Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits | 2019 |
| 144 | MICROX | Microscopy of living cancer cells at physiological oxygen levels: the MICROX platform | 2019 |
| 145 | TargetGBM | Generating a targeted, brain-permeable and stable polymeric nanoparticle for systemic gene delivery to glioblastoma | 2019 |
| 146 | TARGLIO | Improved glioblastoma treatment through targeted, local drug delivery | 2019 |
| 147 | INTRA | The first ultrasound-compatible cranial prosthesis enabling diagnostic and therapeutic use of ultrasound in brain pathologies | 2019 |
| 148 | PROTEUS | Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection | 2019 |
| 149 | SIMCARE | SImulation-assisted Minimally invasive CAncer tREatment using the gosmart environment | 2019 |
| 150 | MS | Unravelling the molecular and cellular mechanism of metastasis | 2020 |
| 151 | RASImmune | Targeting RAS driven tumour immune evasion | 2019 |
| 152 | MABIOS | The first microalgae platform for the production of anticancer biopharmaceuticals | 2019 |
| 153 | TK-NEO | Personalized Cancer Immunotherapy through DNA-EP vaccines | 2019 |
| 154 | VISIOCYT | VISIOCYT SCREENING: A DISRUPTIVE ARTIFICIAL INTELLIGENCE SOLUTION FOR BLADDER CANCER SCREENING | 2019 |
| 155 | RASMAC | Regulatory Approved Software for Mutation Analysis in Cancer | 2019 |
| 156 | ONCORNET2.0 | ONCOgenic Receptor Network of Excellence and Training 2.0 | 2020 |
| 157 | MYCure | Innovative cancer therapy through Myc inhibition: taking OMO-103 to market | 2019 |
| 158 | CellSex | The importance of cellular sex in physiology and the underlying mechanisms | 2020 |
| 159 | HIL PT System | A revolutionary, cost effective, ultra-compact proton therapy system for cancer treatment | 2019 |
| 160 | CSI AurkA-MYC | Conformational Shift Inducers (CSI): An atomistic level investigation of Aurora kinase A (AurkA)–MYC interaction and its distortion by CSI compounds | 2019 |
| 161 | BioTrace | World's First Real-Time Monitoring System for Ablation Procedures | 2019 |
| 162 | EARLYDETECT | Development of an accurate, early diagnostic tool for ovarian cancer | 2020 |
| 163 | CHROMREP | Dissecting the chromatin response to DNA damage in silenced heterochromatin regions | 2019 |
| 164 | STI-001 | Turn Cancer Immunotherapy Effective in Most Patients | 2019 |
| 165 | AMPLITUDE | Advanced Multimodal Photonics Laser Imaging Tool for Urothelial Diagnosis in Endoscopy | 2020 |
| 166 | oncNGS | NGS diagnostics in 21st century oncology: the best, for all, at all times | 2020 |
| 167 | PROSTATOR | Reliable urinary test for the diagnosis of prostate cancer | 2020 |
| 168 | KineTic | New Reagents for Quantifying the Routing and Kinetics of T-cell Activation | 2020 |
| 169 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 170 | NANOCRISPR | NANODELIVERY OF SPECIFIC GENOME ENGINEERING TOOLS AS A NOVEL THERAPEUTIC APPROACH FOR AGGRESSIVE PROSTATE CANCERS | 2021 |
| 171 | PDASwITch | Super-enhancer modules controlling plasticity and response to therapy in pancreatic cancer | 2020 |
| 172 | RCC_Evo | Modelling the Predictability and Repeatability of Tumour Evolution in Clear Cell Renal Cell Cancer | 2020 |
| 173 | HypoCyclo | Multifunctional Polymeric Cyclodextrin Nanocarriers As Novel Triple-Negative Breast Cancer Treatment: A Versatile Photo-Chemotherapy Bypassing Hypoxic Conditions | 2020 |